N-(1,3,4-Thiadiazol-2-yl)benzamide → HCID 10022468, 화합물

HRID 31460

반응식

HRID 31460 반응식
I[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[CH:4][CH:3]=1.S1C=NN=C1NC(=O)C1C=CC=CC=1.[CH3:28][C:29]1[CH:42]=[CH:41][C:32]([C:33]([NH:35][C:36]2[S:37][CH:38]=[N:39][N:40]=2)=[O:34])=[CH:31][C:30]=1B1OC(C)(C)C(C)(C)O1>CC(O)C>[S:37]1[CH:38]=[N:39][N:40]=[C:36]1[NH:35][C:33]([C:32]1[CH:31]=[C:30]([C:2]2[CH:7]=[CH:6][C:5]([C:8]3[O:9][C:10]([CH3:13])=[N:11][N:12]=3)=[CH:4][CH:3]=2)[C:29]([CH3:28])=[CH:42][CH:41]=1)=[O:34]

참가 물질

5

반응물 3

HCID 569548N-(1,3,4-Thiadiazol-2-yl)benzamideHCID 6765692-(4-Iodophenyl)-5-methyl-[1,3,4]oxadiazole2회HCID 586565324-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-N-([1,3,4]thiadiazol-2-yl)-benzamide

생성물 1

HCID 10022468HCID 10022468, 화합물

시약·촉매·용매 1

HCID 3776Isopropanol용매

실험 절차

Example 33 was prepared using 2-(4-iodophenyl)-5-methyl-[1,3,4]oxadiazole (Intermediate 15) and 4-methyl-3-4,4,5,5, -tetramethyl-[1,3,2]dioxaborolan-2-yl)-N-([1,3,4]thiadiazol-2-yl)-benzamide (Intermediate 23) with propan-2-ol as the solvent.

후처리

  1. customExample 33 was prepared

출처 및 근거

ORD 기록
ord-74ea90cb67c241238258eb21066f588f
출처 데이터셋
uspto-grants-2008_09
특허 번호
US07425555B2

연결된 노트

불러오는 중…